Europe’s drug regulatory agency has given Kizfizo a negative opinion for the second time, following one from November 2024.

Edinburgh cancer campaigner Kira Noble, who has been fighting her personal battle with the disease for more than a decade, ...

Neuroblastoma is a solid tumor that occurs in children. When high-risk, the disease has a poor prognosis. Decades ago, adding ...

Neuroblastoma (NB), the most prevalent extracranial solid tumor among children, is characterized by a high rate of metastasis ...

The long-term survival of a patient with neuroblastoma suggests the personalized cancer treatment may work for solid tumors, not just blood cancers.

Neuroblastoma is a solid tumor that occurs in children. When high-risk, the disease has a poor prognosis.

Neuroblastoma is a solid tumor that occurs in children. When high-risk, the disease has a poor prognosis. Decades ago, adding the drug retinoic acid to neuroblastoma treatment increased survival by 10 ...

The following is a summary of "Social Determinants of Health Influence on Survival in Wilms Tumor, Neuroblastoma, and ...

PORTLAND, OR, UNITED STATES, March 11, 2025 /EINPresswire / -- The global neuroblastoma drugs market is witnessi ...

Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel radioimmunotherapy and ...

(A) Experimental scheme for investigating the mechanisms underlying NB-BBM. (B) The sample overviews available for single-cell, whole genome sequencing, pathohistological, and survival data.